RxDoctor Payments Data

Amanda Gross, PA

Physician Assistant · Traverse City, MINPI 1639633076

Payments from drug & device makers

$803in general payments, 2019–2025

Across 29 payments — averaging $27.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$161
  • Neurelis, Inc.$126
  • Amgen$106
  • AbbVie$74
  • AstraZeneca$60
  • Novo Nordisk$57
  • plus $220 from 10 others

What the payments were for

  • Food & beverage$803100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$803 in reported general payments places this provider in the 70th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$26,417
Medicare patients
85
Services billed
398

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$17,497
JardianceEmpagliflozin14$14,652
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$12,158
FarxigaDapagliflozin Propanediol11$7,053
Duloxetine Hcl30$2,275
Atorvastatin Calcium105$1,403
Rosuvastatin Calcium38$1,118
Tamsulosin Hcl28$848
Levothyroxine Sodium53$838
Lisinopril82$820
Omeprazole26$805
Pantoprazole Sodium48$773
Losartan Potassium67$767
Simvastatin31$627
Metformin Hcl ErMetformin Hcl32$569

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$36$17,49711 claims
GSKTrelegy Ellipta$47$12,15812 claims
AstraZenecaFarxiga$60$7,05311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Traverse City

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →